000183919 000__ 01583fam\a2200361\a\4500
000183919 001__ 183919
000183919 005__ 20220217103628.0
000183919 008__ 960917s1996\\\\dcua\\\\\b\\\f000\0\eng\d
000183919 020__ $$a0160529077
000183919 035__ $$a(OCoLC)ocm35568892
000183919 035__ $$9(IS)TVY5492
000183919 035__ $$9AAV2609SI
000183919 035__ $$a183919
000183919 040__ $$aGPO$$cGPO
000183919 043__ $$an-us---
000183919 049__ $$aISUW
000183919 074__ $$a1028-A
000183919 0860_ $$aY 4.W 36:104-40
000183919 088__ $$aSerial 104-40 (United States. Congress. House. Committee on Ways  and Means)
000183919 1101_ $$aUnited States.$$bCongress.$$bHouse.$$bCommittee on Ways and Means.$$bSubcommittee on Health.
000183919 24510 $$aMedicare End-Stage Renal Disease (kidney failure) Program :$$b    hearing before the Subcommittee on Health of the Committee on Ways and Means,   House of Representatives, One Hundred Fourth Congress, first session, April 3,  1995.
000183919 2462_ $$aMedicare End Stage Renal Disease (kidney failure) Program
000183919 260__ $$aWashington :$$bU.S. G.P.O. :$$bFor sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,$$c1996.
000183919 300__ $$aiii, 165 p. :$$bill. ;$$c23 cm.
000183919 500__ $$aDistributed to some depository libraries in microfiche.
000183919 500__ $$aShipping list no.: 96-0346-P.
000183919 500__ $$a"Serial 104-40."
000183919 504__ $$aIncludes bibliographical references.
000183919 61010 $$aUnited States.$$bMedicare Bureau.$$bEnd-Stage Renal Disease Program.
000183919 650_0 $$aChronic renal failure$$xTreatment$$zUnited States$$xFinance.
000183919 650_0 $$aHemodialysis$$zUnited States$$xFinance.
000183919 650_0 $$aKidneys$$xTransplantation$$zUnited States$$xFinance.
000183919 85230 $$bdfich$$hY 4.W 36:$$i104-40
000183919 909CO $$ooai:library.usi.edu:183919$$pGLOBAL_SET
000183919 948__ $$ac:jb
000183919 980__ $$aBIB
000183919 980__ $$aGOV RESOURCE